407 related articles for article (PubMed ID: 38191244)
1. Historical perspective and future directions: computational science in immuno-oncology.
Ricker CA; Meli K; Van Allen EM
J Immunother Cancer; 2024 Jan; 12(1):. PubMed ID: 38191244
[TBL] [Abstract][Full Text] [Related]
2. Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Ascierto PA; Agarwala S; Botti G; Cesano A; Ciliberto G; Davies MA; Demaria S; Dummer R; Eggermont AM; Ferrone S; Fu YX; Gajewski TF; Garbe C; Huber V; Khleif S; Krauthammer M; Lo RS; Masucci G; Palmieri G; Postow M; Puzanov I; Silk A; Spranger S; Stroncek DF; Tarhini A; Taube JM; Testori A; Wang E; Wargo JA; Yee C; Zarour H; Zitvogel L; Fox BA; Mozzillo N; Marincola FM; Thurin M
J Transl Med; 2016 Nov; 14(1):313. PubMed ID: 27846884
[TBL] [Abstract][Full Text] [Related]
3. A review of spatial profiling technologies for characterizing the tumor microenvironment in immuno-oncology.
Hu B; Sajid M; Lv R; Liu L; Sun C
Front Immunol; 2022; 13():996721. PubMed ID: 36389765
[TBL] [Abstract][Full Text] [Related]
4. Artificial Intelligence-based Radiomics in the Era of Immuno-oncology.
Kang CY; Duarte SE; Kim HS; Kim E; Park J; Lee AD; Kim Y; Kim L; Cho S; Oh Y; Gim G; Park I; Lee D; Abazeed M; Velichko YS; Chae YK
Oncologist; 2022 Jun; 27(6):e471-e483. PubMed ID: 35348765
[TBL] [Abstract][Full Text] [Related]
5. Multi-Omics Profiling of the Tumor Microenvironment.
Van Oekelen O; Laganà A
Adv Exp Med Biol; 2022; 1361():283-326. PubMed ID: 35230695
[TBL] [Abstract][Full Text] [Related]
6. Leveraging multi-omics data to empower quantitative systems pharmacology in immuno-oncology.
Arulraj T; Wang H; Ippolito A; Zhang S; Fertig EJ; Popel AS
Brief Bioinform; 2024 Mar; 25(3):. PubMed ID: 38557676
[TBL] [Abstract][Full Text] [Related]
7. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
Front Immunol; 2021; 12():687975. PubMed ID: 34276676
[TBL] [Abstract][Full Text] [Related]
8. Personalized Immuno-Oncology.
Jain KK
Med Princ Pract; 2021; 30(1):1-16. PubMed ID: 32841942
[TBL] [Abstract][Full Text] [Related]
9. Artificial Intelligence for Precision Oncology.
Bhalla S; Laganà A
Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
[TBL] [Abstract][Full Text] [Related]
10. Radiomics and "radi-…omics" in cancer immunotherapy: a guide for clinicians.
Porcu M; Solinas C; Mannelli L; Micheletti G; Lambertini M; Willard-Gallo K; Neri E; Flanders AE; Saba L
Crit Rev Oncol Hematol; 2020 Oct; 154():103068. PubMed ID: 32805498
[TBL] [Abstract][Full Text] [Related]
11. Precision immunoprofiling by image analysis and artificial intelligence.
Koelzer VH; Sirinukunwattana K; Rittscher J; Mertz KD
Virchows Arch; 2019 Apr; 474(4):511-522. PubMed ID: 30470933
[TBL] [Abstract][Full Text] [Related]
12. Immuno-oncology-101: overview of major concepts and translational perspectives.
Allard B; Aspeslagh S; Garaud S; Dupont FA; Solinas C; Kok M; Routy B; Sotiriou C; Stagg J; Buisseret L
Semin Cancer Biol; 2018 Oct; 52(Pt 2):1-11. PubMed ID: 29428479
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology.
Asleh K; Dery V; Taylor C; Davey M; Djeungoue-Petga MA; Ouellette RJ
Biomark Res; 2023 Nov; 11(1):99. PubMed ID: 37978566
[TBL] [Abstract][Full Text] [Related]
14. The Future of Cancer Diagnosis, Treatment and Surveillance: A Systemic Review on Immunotherapy and Immuno-PET Radiotracers.
Liberini V; Laudicella R; Capozza M; Huellner MW; Burger IA; Baldari S; Terreno E; Deandreis D
Molecules; 2021 Apr; 26(8):. PubMed ID: 33920423
[TBL] [Abstract][Full Text] [Related]
15. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
He X; Liu X; Zuo F; Shi H; Jing J
Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
[TBL] [Abstract][Full Text] [Related]
16. Artificial intelligence and digital biomarker in precision pathology guiding immune therapy selection and precision oncology.
Huss R; Raffler J; Märkl B
Cancer Rep (Hoboken); 2023 Jul; 6(7):e1796. PubMed ID: 36813293
[TBL] [Abstract][Full Text] [Related]
17. Novel research and future prospects of artificial intelligence in cancer diagnosis and treatment.
Zhang C; Xu J; Tang R; Yang J; Wang W; Yu X; Shi S
J Hematol Oncol; 2023 Nov; 16(1):114. PubMed ID: 38012673
[TBL] [Abstract][Full Text] [Related]
18. Translational landscape of glioblastoma immunotherapy for physicians: guiding clinical practice with basic scientific evidence.
Kreatsoulas D; Bolyard C; Wu BX; Cam H; Giglio P; Li Z
J Hematol Oncol; 2022 Jun; 15(1):80. PubMed ID: 35690784
[TBL] [Abstract][Full Text] [Related]
19. Advances and Challenges in Interventional Immuno-Oncology Locoregional Therapies.
Altun I; Demirlenk YM; Atar D; Cevik E; Gunduz S; Albadawi H; Oklu R
J Vasc Interv Radiol; 2024 Feb; 35(2):164-172. PubMed ID: 38272636
[TBL] [Abstract][Full Text] [Related]
20. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
Li J; Li L; You P; Wei Y; Xu B
Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
